Axsome Therapeutics (NASDAQ:AXSM) +189% on positive AXS-05 data.
Luxoft Holding (NYSE:LXFT) +82% as DXC acquisition.
Loxo Oncology (NASDAQ:LOXO) +66%. on being acquired by Eli Lilly.
Sage Therapeutics (NASDAQ:SAGE) +42% on positive SAGE-217 data.
QEP Resources (NYSE:QEP) +39% as Elliott Management offers to buy.
Insmed (NASDAQ:INSM) +31% on Arikayce update.
Neptune Wellness Solutions (NASDAQ:NEPT) +24% on Canadian cannabis license.
Clovis Oncology (NASDAQ:CLVS) +13% on announcing revenue for 4Q18 and FY18.
IZEA Worldwide (NASDAQ:IZEA) +12% on record Q4 bookings growth of 115%.
Astrotech (NASDAQ:ASTC) +9% as 1st detect passes Europe's ECAC cargo test and looks to receive ECAC certification in the near-term.
KemPharm (NASDAQ:KMPH) +8% on FDA nod for new Apadaz doses.
Roku (NASDAQ:ROKU) +9% on announcing Westinghouse Roku TV partnership.
Exact Sciences (NASDAQ:EXAS) +8% on Q4 and FY18 sales.
Epizyme (NASDAQ:EPZM) +7%.
Array BioPharma (NASDAQ:ARRY) +7%.
Axovant Sciences (NASDAQ:AXON) +6%.
TransEnterix (NYSEMKT:TRXC) +5% on corporate update.